Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Steven W Spector. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Steven W Spector har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ARNA / Arena Pharmaceuticals Inc EVP, General Counsel & Sec 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Steven W Spector. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Steven W Spector som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2020-02-28 2020-02-27 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -7.970 0 -100,00
2020-02-28 2020-02-27 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 7.970 17.437 84,19 14,90 118.753 259.811
2020-02-14 2020-02-13 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -4.964 2.536 -66,19
2020-02-14 2020-02-13 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.472 1.254 -66,34
2020-02-14 2020-02-13 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.836 9.467 -53,37 55,00 -595.980 520.685
2020-02-14 2020-02-13 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 4.964 20.303 32,36 37,20 184.661 755.272
2020-02-14 2020-02-13 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 2.472 15.339 19,21 32,50 80.340 498.518
2019-10-16 2019-10-14 4 ARNA ARENA PHARMACEUTICALS INC
Performance Restricted Stock Unit
M - Exercise -6.300 18.900 -25,00
2019-10-16 2019-10-14 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
F - Taxes -3.123 12.867 -19,53 47,32 -147.780 608.866
2019-10-16 2019-10-14 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 6.300 15.990 65,02
2019-09-10 2019-09-10 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -12.627 27.500 -31,47
2019-09-10 2019-09-10 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -12.627 9.690 -56,58 50,28 -634.873 487.204
2019-09-10 2019-09-10 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 12.627 22.317 130,31 15,50 195.718 345.914
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -12.373 40.127 -23,57
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -5.810 9.189 -38,74
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -3.274 3.726 -46,77
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.257 9.690 -51,42 51,23 -525.428 496.383
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -21.200 19.947 -51,52 50,48 -1.070.087 1.006.841
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 12.373 41.147 43,00 15,50 191.782 637.778
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 5.810 28.774 25,30 17,90 103.999 515.055
2019-09-10 2019-09-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 3.274 22.964 16,63 32,50 106.405 746.330
2019-02-04 2019-02-01 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.500 0 -100,00
2019-02-04 2019-02-01 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -1.500 19.690 -7,08 46,10 -69.150 907.709
2019-02-04 2019-02-01 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 1.500 21.190 7,62 40,10 60.150 849.719
2019-01-08 2019-01-04 4 ARNA ARENA PHARMACEUTICALS INC
Employee Performance Restricted Stock Unit
A - Award 12.600 12.600
2019-01-08 2019-01-04 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 75.000 75.000
2018-08-17 2018-08-15 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -29.005 5.525 -84,00
2018-08-17 2018-08-15 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -3.943 19.690 -16,68 36,69 -144.676 722.464
2018-08-17 2018-08-15 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -25.062 23.633 -51,47 35,90 -899.829 848.522
2018-08-17 2018-08-15 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 29.005 48.695 147,31 18,10 524.990 881.380
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -15.000 34.530 -30,28
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -15.001 14.999 -50,00
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -1.400 19.690 -6,64 35,81 -50.135 705.113
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -7.700 21.090 -26,75 35,00 -269.467 738.059
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -20.901 28.790 -42,06 34,33 -717.456 988.257
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 15.000 49.691 43,24 18,10 271.500 899.407
2018-04-18 2018-04-16 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 15.001 34.691 76,19 17,90 268.518 620.969
2018-03-06 2018-03-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
F - Taxes -3.874 19.690 -16,44 42,80 -165.807 842.732
2018-03-06 2018-03-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 11.205 23.564 90,66
2018-01-22 2018-01-19 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 130.000 130.000
2017-12-19 2017-12-17 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
F - Taxes -281 12.359 -2,22 30,23 -8.495 373.613
2017-12-19 2017-12-15 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
F - Taxes -234 12.640 -1,82 30,23 -7.074 382.107
2017-02-14 2017-02-13 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 1.044.750 1.044.750
2016-12-16 2016-12-15 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 342.000 342.000
2016-03-04 2016-03-02 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 525.000 525.000
2015-12-17 2015-12-15 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 300.000 300.000
2015-03-18 2015-03-17 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -4.698 495.302 -0,94
2015-03-18 2015-03-17 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -65.302 79.698 -45,04
2015-03-18 2015-03-17 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -70.000 128.039 -35,35 5,00 -350.000 640.195
2015-03-18 2015-03-17 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 4.698 198.039 2,43 1,81 8.503 358.451
2015-03-18 2015-03-17 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 65.302 193.341 51,00 1,49 97.300 288.078
2015-01-08 2015-01-08 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -45.000 0 -100,00
2015-01-08 2015-01-08 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -45.000 128.039 -26,01 6,26 -281.700 801.524
2015-01-08 2015-01-08 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 45.000 173.039 35,15 6,16 277.200 1.065.920
2014-12-17 2014-12-15 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 75.000 75.000
2014-12-17 2014-12-15 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 25.000 127.687 24,35
2014-05-14 2014-05-12 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -45.000 145.000 -23,68
2014-05-14 2014-05-12 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -45.000 102.187 -30,57 7,05 -317.358 720.664
2014-05-14 2014-05-12 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 45.000 147.187 44,04 1,49 67.050 219.309
2014-03-05 2014-03-04 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -25.000 190.000 -11,63
2014-03-05 2014-03-04 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -100 101.794 -0,10 7,01 -701 713.830
2014-03-05 2014-03-04 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -24.900 101.894 -19,64 7,01 -174.549 714.277
2014-03-05 2014-03-04 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 25.000 126.794 24,56 1,49 37.250 188.923
2014-01-13 2014-01-09 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -33.334 0 -100,00
2014-01-13 2014-01-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -33.334 101.794 -24,67 6,10 -203.337 620.943
2014-01-13 2014-01-09 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 33.334 135.128 32,75 6,00 200.004 810.768
2013-12-18 2013-12-17 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 100.000 100.000
2013-12-18 2013-12-17 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 30.000 101.420 42,01
2013-11-13 2013-11-12 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -20.000 215.000 -8,51
2013-11-13 2013-11-12 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 71.420 -21,88 5,19 -103.710 370.348
2013-11-13 2013-11-12 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 91.420 28,00 1,49 29.800 136.216
2013-09-06 2013-09-05 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -20.000 235.000 -7,84
2013-09-06 2013-09-05 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 71.046 -21,97 6,54 -130.726 464.378
2013-09-06 2013-09-05 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 91.046 28,15 1,49 29.800 135.659
2012-12-17 2012-12-13 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 100.000 100.000
2012-12-17 2012-12-13 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 30.000 69.943 75,11
2012-07-03 2012-07-03 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -22.300 15.001 -59,78
2012-07-03 2012-07-03 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -22.300 39.588 -36,03 10,05 -224.115 397.859
2012-07-03 2012-07-03 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 22.300 61.888 56,33 4,01 89.423 248.171
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -45.000 255.000 -15,00
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -30.000 70.000 -30,00
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -22.699 37.301 -37,83
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -16.666 33.334 -33,33
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -39.365 39.588 -49,86 10,04 -395.134 397.372
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
S - Sale X -95.000 78.953 -54,61 9,96 -946.048 786.246
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 45.000 173.953 34,90 1,49 67.050 259.190
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 128.953 30,32 3,25 97.500 419.097
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 22.699 98.953 29,77 4,01 91.023 396.802
2012-07-03 2012-07-02 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
M - Exercise 16.666 76.254 27,97 6,00 99.996 457.524
2012-03-19 2012-03-19 4 ARNA ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 500.000 500.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)